Endometrial polyps (EP), a prevalent benign gynecological disease, with an incidence of 7.8%-34.9% (Anonymous, 2012; Salim et al., 2011), is characterized by excessive growth of glands, stromal cells and blood vessels in the endometrium, which is usually associated with abnormal uterine bleeding (AUB). According to some studies, EP is associated with chronic endometritis (CE) (El-Hamarneh et al., 2013), whereas CE may result from an overgrowth of Ureaplasma urealyticum or common bacteria (Cicinelli et al., 2009). Thus, the EP may be related to the prolonged existence of certain microorganisms. The vaginal and uterine microbiomes of patients with EP, patients with EP and CE, and healthy women were compared in a 2016 study with 10 subjects in each group. It was discovered that while Proteobacteria, Firmicutes, and Actinobacteria dominated the intrauterine microbiota of all samples, the proportion of Proteobacteria was much lower in patients with EP than that of healthy women, while the proportion of Firmicutes was significantly higher than that of healthy women. In addition, the proportion of Pseudomonas was significantly lower in patients with EP, while the proportion of Lactobacillus, Gardnerella, Bifidobacterium, Streptococcus, and Alteromonas was significantly higher than the control group. Patients with EP generally had a more diverse intrauterine microbiome than the control group. Whether EP patients were with CE or not had no significant effect on their intrauterine microbiome (Fang et al., 2016). It is worth noting that this study included healthy women as the control group, which few other studies did. These women underwent hysteroscopy and laparoscopy because of infertility of their male partners, while they had regular menstrual cycles and no structural abnormalities of the uterus. This eliminates the interference, making it possible to figure out the characteristic bacteria of the disease.

Liang et al. prospectively collected vaginal, cervical and uterine microbiological samples from 134 infertile patients. They found that the microbiota in the reproductive tracts of patients with CE and EP differed from that of the healthy control group. For example, compared with the control group, the distribution of Firmicutes throughout the reproductive tract of EP patients was significantly increased. In contrast, the distribution of Proteobacteria was significantly lower, which is consistent with the findings of previous studies. In contrast to previous studies, the abundance of Lactobacillus in the EP group was lower than that in the control group (Liang et al., 2023). Their study was an essential reference for subsequent research because it included a sufficient sample size and adequate sampling locations. Future research on the microbiome of endometrial polyps may focus on specific clinical problems, such as recurrence and response to treatment, to identify suitable biomarkers or therapeutic targets.

Leiomyomas, or uterine fibroids, are the most prevalent benign gynecological neoplasms. They are characterized by muscle and fibrous tissue growths that can cause infertility, heavy or prolonged menstrual bleeding, anemia (Donnez and Dolmans, 2016; Zepiridis et al., 2016), and significant personal and social problems (Millien et al., 2021). There is an increasing understanding of hormones, genetics, epigenetics, and growth factors in the development and progression of uterine fibroids (Torres-de-la-Roche et al., 2017); however, the exact pathogenesis is still unclear. According to some research, bacteria may cause inflammation that contributes to the pathogenesis of uterine fibroids. A study reported that the TLR4/MyD88/NFKB signaling pathway in primary cultured human fibroblasts from leiomyomas was activated under E. coli LPS treatment, which suggested that bacteria may be involved in the pathogenesis of leiomyomas by inducing cell proliferation through inflammation (Guo et al., 2015).

According to a study comparing the microbiota of the vagina, cervix, endometrium, and pouch of Douglas in 20 patients with leiomyoma and controls, Lactobacillus sp. was found to be less abundant in the vaginal and cervical samples from leiomyoma patients, but L. iners was more abundant in the cervix (Chen et al., 2017). There was no significant difference in microbial diversity between patients with leiomyoma and controls in another study that examined the vaginal and cervical microbiomes of 29 patients with leiomyoma and 38 healthy women. Interestingly, alpha diversity decreased in patients with leiomyoma as the number of fibroids increased. At the phylum level, an increase in Firmicutes in the vagina and cervix was observed in patients with leiomyoma. Erysipelotrichaceae UCG-003 and Sporolactobacillus were significantly less common in patients with leiomyoma, whereas Erysipelatoclostridium, Mucispirillum, and Finegoldia were significantly enriched in the differential analysis of relative abundance. Moreover, the microbial co-occurrence networks exhibiting lower connectivity and complexity in patients with leiomyoma suggested decreased interactions and stability of the microbiota in these patients compared to healthy individuals (Mao et al., 2023). The research mentioned above revealed the characteristic microbiome of the reproductive tract associated with leiomyoma, provided clear evidence of microbial dysbiosis in patients with leiomyoma, and restricted the scope of screening for associated microorganisms potentially implicated in the pathogenesis of leiomyoma. More research is required to fill the knowledge gap of microbial dysbiosis and leiomyoma interaction.

Endometriosis, a gynecological disease that affects 6%-10% of women of childbearing age worldwide, is characterized by the growth of endometrial tissue outside the uterus, including glands and stroma. This disease results in progressive secondary dysmenorrhea and difficulty in having sexual intercourse as well as infertility (Dai et al., 2018). The pathogenesis of endometriosis has not been clarified yet, and scientists are primarily interested in the retrograde menstruation hypothesis. However, 90% of the women have retrograde menstruation, while only 10% have the disease (Akiyama et al., 2019; Bellelis et al., 2019; Gueuvoghlanian-Silva et al., 2018; Khan et al., 2018; Zhang et al., 2018), indicating that other factors may play a role in the pathogenesis of endometriosis. Research has demonstrated that the abundance of bacterial colonization in menstrual blood and endometrial tissue of patients with endometriosis is higher than that of average female (Khan et al., 2018, 2016). Therefore, it is essential to investigate if the microbiome of the reproductive tract is involved in the pathogenesis of endometriosis.

There is more clinical research on endometriosis and microbiome than on uterine fibroids and endometrial polyps (Akiyama et al., 2019; Ata et al., 2019; Chang et al., 2022; Chao et al., 2021; Chen et al., 2020; Hernandes et al., 2020; Huang et al., 2021; Le et al., 2022; Lu et al., 2022; Oishi et al., 2022; Perrotta et al., 2020; Wei et al., 2020; Wessels et al., 2021). In terms of vaginal microbiome, it was discovered that Lactobacillus was less common in the vaginal microbiome of patients with endometriosis than in the control group (Chao et al., 2021; Findeklee et al., 2023; Hernandes et al., 2020; Lu et al., 2022). The vaginal microbiome of patients with stages III or IV endometriosis and healthy women were compared by Ata et al (Ata et al., 2019). Patients with endometriosis did not have any detections of Gemella and Atopobium spp. Another research studied community state type (CST) in greater detail (Perrotta et al., 2020). They used machine learning methods to construct a classification model based on random forest to predict the Revised American Society for Reproductive Medicine (r-ASRM) stage of endometriosis. The study discovered that the Anaerococcus from the Firmicutes phylum could predict whether patients had stage I-II or III-IV endometriosis after accounting for the menstrual cycle. As the vaginal sample is convenient to obtain, the above research findings have great clinical application potential.

In terms of cervical microbiome, Akiyama et al. demonstrated that compared with the control group, patients with endometriosis had higher levels of Corynebacterium, Enterobactericaea, Flavobacterium, Pseudomonas, and Streptococcus in their cervical microbiota (Akiyama et al., 2019). NGS results were further confirmed using a real-time polymerase chain reaction to quantify bacteria. They found a statistically significant difference in the abundance of Enterobacteriaceae and Streptococcus between endometriosis and control. Furthermore, patients with stage I-II endometriosis and those with stage III-IV endometriosis exhibit differences in cervical microbiomes. For stages I and II, the researchers suggested L. jensenii or members of the Corynbacteriales, Porphyromonadaceae, and Ruminococcaceae as potential microbial biomarkers; for stages III and IV, they suggested Bifidobacterium breve and members of Streptococcaceae (Chang et al., 2022). Studies on vaginal and cervical microbiota of patients with endometriosis have shown an increase in the abundance of some low-abundance genera, including Fannyhessea, Prevotella, Streptococcus, Bifidobacterium, and Veillonella. The degree of endometriosis is correlated with the ratio of the cervical to vaginal abundance of these genera (Yang et al., 2023), indicating that specific genera may migrate between the vagina and cervix and contribute to the pathogenesis of endometriosis.

In the aspect of endometrial microbiome, a study included 12 patients with endometriosis and 9 subjects without endometriosis. It was found that among individuals with endometriosis, the abundance of the Tepidimonas genus and Oxalobactaceae and Streptococcaceae families increased, whereas the Ralstonia genus and Burkholderiaceae family decreased (Wessels et al., 2021). Another study included 36 patients with endometriosis and 14 control subjects and discovered a significant increase in Pseudomonadaceae in endometriosis. Notably, there was a significant increase in Sphingobium sp. and Pseudomonas viridiflava in the endometrium and peritoneal fluid in endometriosis (Wei et al., 2020), indicating that these could be potential biomarkers.

According to some researchers, an imbalance in microbiota may disrupt the immune system, which could increase pro-inflammatory cytokines, disrupt immune surveillance, and change the profiles of immune cells. This immune disorder could become chronic inflammation, creating a vicious cycle leading to endometriosis (Jiang et al., 2021). Thus, research is being done on how to treat endometriosis by regulating the balance of microbiota. Patients with endometriosis had a significantly higher positive Fusobacterium rate in their endometrium than the control group. Following Fusobacterium infection of endometrial cells, the transforming growth factor-β signal pathway was activated, resulting in the transformation of quiescent fibroblasts into transgelin-positive myofibroblasts, which obtained the ability of adhesion, migration and proliferation in vitro. In the mouse model, the inoculation of Fusobacterium increased the number and weight of lesions of endometriosis, while therapy with metronidazole and chloramphenicol decreased the lesion. These results showed that endometriosis pathogenesis might involve Fusobacterium infection (Muraoka et al., 2023). Another study using animal models showed that the use of antibiotics or vaginal flora transplants in the vagina effectively treated endometriosis in mice (Lu et al., 2022). In this study, endometriosis mouse models were first established, then 10 mice received vaginal microbiota transplants from healthy mice, and 10 served as controls. The group receiving the vaginal microbiota transplant exhibited smaller endometriotic lesions compared to the control group (p < 0.05). The expression levels of cell proliferation marker Ki-67 and macrophage marker Iba-1 were both reduced in the transplant group. In terms of inflammatory cytokines, the levels of IL-1β, IL-6, and TNF-α in the peritoneal fluid of the microbiota-transplanted mice were lower than those in the control group. Additionally, the expression of TLR4, MyD88, and p65/p-p65 (NF-κB signaling pathway) in the lesions of the microbiota-transplanted mice was downregulated. Taken together, these results suggest that vaginal microbiota transplantation may modulate immune responses by regulating signaling pathways such as NF-κB and influencing the levels of inflammatory cytokines, thereby inhibiting the progression of endometriosis. Furthermore, this study implies that reproductive tract microbiota transplantation may have potential therapeutic effects not only for infections such as bacterial vaginosis but also for gynecological disorders like endometriosis. In patients with stage III and IV endometriosis, oral Lactobacillus gasseri OLL2809 relieved pain, according to a placebo-controlled randomized clinical trial (Khan et al., 2018). Another study discovered oral levofloxacin decreased cell proliferation, inflammation, and angiogenesis in endometrium and endometriosis lesions (Khan et al., 2021). The abovementioned studies demonstrated the promising future of the therapy targeted dysbacteriosis in treating endometriosis.

Adenomyosis is a benign disease characterized by the invasion of endometrial glands and stroma into the myometrium, resulting in uterine enlargement, increased menstrual bleeding, prolonged menstruation, and progressively deteriorating dysmenorrhea. It is common among women of childbearing age. The reproductive tract microbiome of adenomyosis is currently the topic of many studies. A study analyzed the vaginal, cervical and uterine microbiota of patients with adenomyosis, patients with endometriosis, patients with both adenomyosis and endometriosis, and healthy women. It revealed that Atopobium was more abundant in patients with both adenomyosis and endometriosis simultaneously than in the other three groups (Chen et al., 2020). A cross-validated random forest model based on operational taxonomic units (OTUS) from the vagina, cervix, or uterus was developed to differentiate patients with and without adenomyosis (Chen et al., 2017). Studies with larger sample sizes have revealed that patients with adenomyosis had a higher alpha diversity of vaginal microbiota than the control group. In adenomyosis, the abundance of Alloscardovia, Oscillospirales, Ruminoccoccaceae, etc. increased, while the abundance of Megaspehera, Fastidiosipila, Hungateiclostridiaceae, and Clostridia decreased. While CST-III and IV were dominant in adenomyosis, CST-IV dominated the control group (Kunaseth et al., 2022). Another study focused on the endometrial microbiome and found that Citrobacter freundii, Prevotellacopri, and Burkholderiacepacia are the most promising microbial biomarkers for adenomyosis (Lin et al., 2023). The clinical application of these findings and the clarification of the adenomyosis pathogenesis require further study.

Endometrial hyperplasia, characterized by an increase in the number of dilated glands and the ratio of glands to stroma, is commonly diagnosed worldwide, which can coexist or gradually progress into endometrial cancer (Sanderson et al., 2017). Some patients with endometrial hyperplasia have irregular uterine bleeding, while others may not exhibit any symptoms at all and are only diagnosed during routine physical examinations. In terms of pathogenesis, this disease occurs by a microenvironment high in estrogen and a heightened inflammatory response (Kubyshkin et al., 2016). Atypical hyperplasia, a subtype of endometrial hyperplasia, is a premalignant lesion of endometrial carcinoma, receiving clinical attention. Because of the heterogeneity of endometrial hyperplasia, it is necessary to make a sensitive and accurate diagnosis of the actual premalignant lesions and the appropriate course of treatment are required. The disease must primarily be distinguished from normal proliferative endometrium and endometrial carcinoma. The main non-invasive auxiliary examination is an ultrasound; invasive surgery is required to collect the histopathology results to confirm the diagnosis. Clinically, ultrasonic measurement is significantly influenced by the technology and the operator, and it is more challenging to monitor in situations like obesity. The extent of endometrial hyperplasia is frequently restricted; hence, the ultrasound readings can occasionally be inaccurate. In clinical practice, it is easy to underestimate and overestimate the lesions. This clinical situation needs to be fixed. On the one hand, invasive procedures such as endometrial sampling or uterine curettage for women with simple hyperplasia or even normal proliferative endometrium is a type of excessive medical treatment, which not only results in a waste of medical resources but also the potential complications of these operations, such as uterine adhesion and infection, may harm these women, especially since the majority of these women are of childbearing age. On the other hand, misdiagnosing endometrial cancer as endometrial hyperplasia, or even misdiagnosing endometrial cancer and endometrial hyperplasia as normal endometrium, may result in errors in the selection of treatment and delay in the initiation of necessary treatment, which in the former case will prompt over-the-top medical care. Therefore, there is no doubt that the study of reproductive tract microbiota of endometrial hyperplasia is meaningful, which may help clarify the pathogenesis of endometrial hyperplasia and find suitable biomarkers for clinical diagnosis.

At present, most reproductive tract microbiome studies on endometrial hyperplasia studied endometrial carcinoma at the same time, and some studies even combined the two diseases into one group (Chao et al., 2022). A study published in 2016 included 4 patients with endometrial hyperplasia, 17 with endometrial carcinoma, and 10 with other benign gynecological diseases (Walther-António et al., 2016). The uterine α diversity in the hyperplasia group was similar to that in the carcinoma group, and was significantly higher than that in the benign group. Significant differences in the overall microbial flora structure among the three groups, mainly in the uterus rather than the vagina, were consistent with the α diversity analysis. The paired comparison of uterine samples showed no difference between endometrial hyperplasia and endometrial carcinoma. Simultaneously, there was a difference between the two groups and benign group respectively. According to the microbiome perspective, endometrial hyperplasia is the transitional stage from normal endometrium to endometrial cancer. The difference in the microbiota of endometrial hyperplasia from endometrial carcinoma and benign diseases makes exploring its characteristic microbial biomarkers possible. It is important to note that although correlation does not imply causation, the fact that two microorganisms found to be closely related to endometrial cancer, A. vaginae and Porphyromonas sp., did not exist in the vagina in endometrial hyperplasia, but exist in the uterine of half of the patients with endometrial hyperplasia, supported the role of these two microorganisms in early diseases, when taking into account the distance from the sample sites to the location of the disease. The primary shortcoming of this study is the insufficient number of patients with endometrial hyperplasia. Hence, the credibility of the relevant conclusions is low. Second, because the menopause and menstrual cycle were not considered in the design of the study, and because the factors mentioned above can affect the microbiome by hormone levels, it is crucial to evaluate the findings of this study carefully.

Another study included 26 patients with AUB and endometrial thickening identified by transvaginal ultrasound. Twelve of these patients had endometrial hyperplasia, and 14 had proliferative endometrium. In contrast to the previous study, it was discovered that the diversity of the vaginal microbial community in endometrial hyperplasia was much smaller than that in proliferative endometrium. This discrepancy may have resulted from differences in sample size, race, age, and other factors (Moosa et al., 2020). There were significant differences in the abundance of Lactobacillus in 15 genera, and if its abundance is used in the differential diagnosis of endometrial thickening, the sensitivity is 93%, and the specificity is 75% (Zhang et al., 2021). This study has a relatively sufficient sample size, and the choice of the control group is suitable for addressing clinical issues. Still, it ignores the impact of menstruation and menopause on the microbiome. According to the microbiome structure, endometrial hyperplasia can generally be distinguished from proliferative endometrium, suggesting that the microbiome may play a role in the development of the disease or that the difference may be a series of physiological changes in the local microenvironment brought on by the disease.

Even though the most recent study had a bigger sample size, it still mixed up pre-menopausal and post-menopausal patients, and its focus was only on the cervix and vagina (Barczyński et al., 2023). These research findings may aid in early detection and screening of endometrial hyperplasia using non-invasive techniques, given the accessibility of vaginal and cervical samples. However, the investigation of endometrial microbiota is more likely to further our understanding of pathogenesis. In general, we still know very little about the microbiome of endometrial hyperplasia and its subtypes, and the current research still has room to learn from the microbiome research of other diseases in terms of research design, as there are still a lot of open questions.

Endometrial cancer is a common malignant tumor of the female reproductive system. Its pathogenesis has not been thoroughly elucidated, and genetics can only account for 20% of the incidence of endometrial cancer (Hampel et al., 2006). The remaining 80% of the causes could be related to hormones (Beral et al., 2005), diabetes (Friberg et al., 2007), and other potential pathogenic factors, and studies on these factors are intended to establish focused preventive interventions. It is proposed that dysbiosis may contribute to the activation of inflammatory pathway in endometrial cancer. Therefore, considerable research has investigated the interaction between the reproductive tract microbiota and endometrial cancer ( Table 1 ).

A paper published in 2016 found that Firmicutes, Actinobacteria and Bacteroidetes were more common in endometrial cancer than in benign uterine diseases. The sensitivity of combination of A. vaginae and the Porphyromonas sp. to diagnose endometrial carcinoma was 73%-93%, and the specificity was 67%-90% (Walther-António et al., 2016). Although there are a few drawbacks, it pioneers the way for future research. In a study released in 2019 that further examined how host variables influence the microbiome characteristics in endometrial cancer, and the post-menopausal state was found to be the primary driver of the network connected to endometrial cancer. When P. somerae was considered a predictive biomarker of endometrial cancer in all patients, the study found that the sensitivity of vaginal P. somerae was 74% and the specificity was 63%. In post-menopausal and obese patients, who were generally thought to be at high risk for endometrial cancer, the positive predictive value increased to 0.86. The study also focused on type I and type II endometrial cancers, two pathophysiological subtypes. Type I endometrial carcinoma, the endometrioid carcinoma, accounts for 70% to 80% of endometrial carcinoma, which frequently develops due to endometrial hyperplasia (Bansal et al., 2009). Type II typically has a p53 gene mutation, which is more aggressive and has a worse prognosis. Early detection is crucial because Type II endometrial carcinoma sometimes lacks early symptoms like post-menopausal bleeding. Type I endometrial carcinoma is estrogen-dependent, while type II is not sensitive to estrogen. The study found that P. somerae was present in the vagina of all patients with type II endometrial cancer and 57% of patients with endometrial hyperplasia (Walsh et al., 2019), indicating that it is a suitable microbial marker for endometrial cancer. However, the use of P. somerae in diagnosing pre-menopausal and peri-menopausal endometrial cancer should be emphasized as constrained.

In a study of bacterial, archaea, and viral transcript (BAVT) in the tumor tissues of serous ovarian cancer and endometrioid endometrial cancer, and healthy fallopian tubes, the authors found that 93 BAVTs were expressed differentially in these three groups. Furthermore, the expression of 12 independently expressed BAVT in endometrioid endometrial cancer was higher than that in ovarian cancers and lower than that in healthy fallopian tubes. Potential targets for cancer therapy in the future may include the pathways connected to these BAVT (Gonzalez-Bosquet et al., 2021). Further study found that microbial communities of the uterus correlated with genetic variation (Gonzalez-Bosquet et al., 2023). The study validated these results in separate datasets, the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus databases, strengthening the reliability and universality of the research conclusions. However, it did not control confounding variables like age and menopause. Another study explored the relationship between endometrial microbiota, the expression of inflammatory cytokines, mRNA and proteins of interleukin (IL)-6, IL-8 and IL-17, and disease state. It was noted that there were notable differences in 12 genera between the endometrial cancer group and the benign uterine disease control group. Micrococcus was more abundant in the endometrial cancer group, while other genera were less in the endometrial cancer group. In terms of inflammatory factors, this study found that endometrial cancer had higher mRNA expression of IL-6, IL-8 and IL-17, and higher levels of IL-6 protein than control. Rank correlation analysis showed a positive correlation between the relative abundance of Micrococcus and mRNA of IL-6 and IL-17 (Lu et al., 2021). This study has a substantial number of samples, but unfortunately the menopausal status of patients was not adequately considered in the study design, and there was a statistical difference in age between the endometrial cancer group and the control group. The range of applications for the results must be determined by additional research. Another article published in 2021 examined for the first time the correlation between endometrial microbiota and tumor transcriptome in endometrial cancer and the relation between endometrial microbiota and blood coagulation indicators. Pelomonas and Prevotella were more abundant in the endometrial cancer than the benign uterine disease control. Further study showed that Prevotella abundance was positively correlated with serum D-dimer (DD) and fibrin degradation products (FDPs). The microorganism-related transcriptome of tumor tissue provided an explanation for the correlation. Prevotella, combined with DD and FDPs, had excellent potential for predicting endometrial cancer existence (Li et al., 2021). It should be carefully considered whether this conclusion may be generalized to younger pre-menopausal and peri-menopausal patients with endometrial cancer because the patients included in this study were relatively old.

A study focused on the vaginal microbiota at various endometrial cancer malignancy levels. It reported that Fusobacterium nucleatum was more abundant in high-grade endometrial carcinoma than in benign gynecologic disease. The diversity increased greatly from benign to high-grade endometrial carcinoma and the benign condition, low-grade endometrial carcinoma and high-grade clustered into CST1, CST 2, and both CST3 and CST4, respectively (Hakimjavadi et al., 2022). The limitation of this study is that there were significant differences across groups in several clinical and demographic characteristics, including age and ethnicity. Another article in 2022 focused on postmenopausal endometrioid adenocarcinoma. It compared and analyzed the microbiota of tumor tissue and paracancerous tissue, and discovered that the α diversity and evenness of tumor tissue were significantly higher than those of paracancerous tissue, and Prevotella, Atopobium, and Porphyromonas were more abundant in the tumor tissue (Wang et al., 2022).

Lean and obese mice models were utilized to test the hypothesis that the endometrial microbiota is associated with obesity and endometrial cancer. It was found that obesity was unrelated to the type of microbial community in mouse endometrium. In humans, the abundance of Lactobacillus in the endometrium of postmenopausal patients with endometrial carcinoma was decreased compared with patients without endometrial carcinoma, but obesity did not have association with its abundance. In mice, the abundance of Lactobacillus was positively correlated with healthy uterine histology (Kaakoush et al., 2022). These findings suggested that Lactobacillus may preserve the endometrium, whereas endometrial carcinoma and obesity may impact the microorganisms living within the endometrium. Another study looked into how race as a demographic characteristic affected the microbiota. In contrast to black women, white women had lower Firmicutes, Cyanobacteria, and OD1 levels in their endometrial cancers, according to this study (Hawkins et al., 2022). TCGA database was used creatively in this study, which future researchers should note. A study based on TCGA database found that the abundance of 11 common microbes changed with different microsatellite instability (MSI) status in endometrial carcinoma, colorectal cancer and stomach adenocarcinoma (Byrd et al., 2023) which indicated that the intratumor microbiota may be different with various MSI status and affect the tumor microenvironment.

Despite the availability of numerous technological techniques, there is still a lack of research on premenopausal endometrial cancer. It is important to note that in clinical practice, the pathology of endometrial biopsy or curettage may be inconsistent with the pathology of hysterectomy, which makes it challenging for a portion of young patients to choose the appropriate therapy, as they may desire to preserve reproductive function. In the present, they can only rely on inaccurate biopsy pathological results when making treatment choices. Therefore, if we can figure out suitable microbial biomarkers to assist in determining determinthe pathological subtype of premenopausal endometrial carcinoma, whether to retain reproductive function or not will be decided with more certainty.